Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts

Laboratory Investigation

Volumn 78, Issue 5, 1998, Pages 535-539

  Migita, Kiyoshi ^a   Kawabe, Yojiro ^a   Tominaga, Masahiro ^a   Origuchi, Tomoki ^a   Aoyagi, Takahiko ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ureshino Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; GELATINASE A; MATRIX METALLOPROTEINASE; MESSENGER RNA; SERUM AMYLOID A; STROMELYSIN;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; JOINT DESTRUCTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; SYNOVIUM;

ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOHEXIMIDE; FIBROBLASTS; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; SYNOVIAL MEMBRANE; TRANSCRIPTION, GENETIC;

EID: 0031805385     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Badolato R, Johnston JA, Wang JM, McVicar D, Xu LL, Oppenheim JJ, and Klevin DJ (1995). Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by a pertussis toxin-sensitive signaling pathway. J Immunol 155:4004-4010.
2. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Klevin DJ, and Oppenheim JJ (1994). Serum amyloid A is a chemoattractant, induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180:203-202.
3. Brinckerhoff CE, Mitchell TI, Karmilowicz MJ, Kluve-Beckerman B, and Benson MD (1989). Autocrine induction of collagenase by serum amyloid A-like and β-microglobulin-like proteins. Science 243:655-657.
4. Cohen AS, Shirahama T, Sipe D, and Skinner M (1983). Amyloid proteins, precursors, mediators and enhancer. Lab Invest 48:1-4.
5. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168.
6. 2 production by human synovial cells. J Clin Invest 77:645-648.
7. De Beer FC, Mallya P, Fagam EA, Lanham JG, Hughes GRV, and Pepys MB (1982). Serum amyloid-A protein concentration in inflammatory disease and its relationship to the incidence of reactive systemic amyloidosis. Lancet 8292: 231-233.
8. Glenner GG (1980a). Amyloid deposits and amyloidosis: The β-fibrilloses I. N Engl J Med 302:1283-1299.
9. Glenner GG (1980b). Amyloid deposits and amyloidosis: The β-fibrilloses II. N Engl J Med 302:1333-1343.
10. Hembry RM, Bagga MR, Reynolds JJ, and Hamblen DL (1995). Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54:25-32.
11. Matrisian LM (1990). Metalloproteinase and their inhibitors in tissue remodelling. Trends Genet 6:121-125.
12. McCachren SS (1991). Expression of metalloproteinases and metalloproteinase inhibitor in human arthritis. Arthritis Rheum 36:372-379.
13. Okada Y, Nagase H, and Harris ED Jr (1986). A metalloproteinase from rheumatoid synovial fibroblasts that digests connective tissue matrix components: Purification and characterization. J Biol Chem 261:14245-14255.
14. Okada Y, Takeuchi N, Tomita K, Nakanishi I, and Nagase H (1989). Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovial fibroblasts (B cells): Correlation with rheumatoid arthritis. Ann Rheum Dis 48:645-653.
15. Saus J, Quinones S, Otani Y, Ngase H, Harris ED Jr, and Kurkinen M (1988). The complete primary structure of human matrix metalloproteinase-3. J Biol Chem 263:6742-6745.
16. Scheinberg MA and Benson MD (1980). SAA amyloid protein in amyloid-prone chronic inflammatory disorder: Lack of association with amyloid disease. J Rheumatol 7:724-726.
17. Steel DM and Whitehead AS (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:81-88.
18. Sukenik S, Henkin J, Zimlichman S, Skibin A, Neuman L, Pras M, Horwitz J, and Shainkin-Kestenbaum R (1988). Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis. J Rheumatol 15:942-945.
19. Unemori EN, Hibbs MS, and Amento EP (1991). Constitutive expression of a 92-kD Gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88:1656-1662.
20. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, and Lark MW (1992). Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee joint injury. Arthritis Rheum 35:35-42.
21. Woessner JF (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.
22. Wolfe GC, MacNaul KL, Buechel FF, McDonnell J, Hoerrner LA, Lark MW, Moore VL, and Hutchinson NJ (1993). Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: Quantitative comparison with stromelysin in osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 36:1540-1547.
23. Yamada T, Nomata Y, Sugita O, and Okada MA (1993). Rapid method for measuring serum amyloid A protein by latex agglutination nephelometric immunoassay. Ann Clin Biochem 30:72-76.
24. Zvaifler NJ and Firestein GC (1994). Pannus and pannocytes: Alternative models of destruction in rheumatoid arthritis. Arthritis Rheum 37:783-789.